Growth Hiring Recent executive hiring, including a new Chief Financial Officer and a Co-Founder CEO, signals strategic scaling and potential demand for enterprise finance systems, ERP integration, and investor relations solutions as the company expands.

Funding Momentum Funding of eleven million dollars coupled with early revenue indicates a growth trajectory and openness to technology partnerships, contract development, and clinical trial collaborations that can benefit from scalable data, manufacturing, or regulatory services.

RITe Platform The rapid infusion technology platform represents a core differentiator; explore opportunities in manufacturing automation, process optimization, analytical testing, and compliance solutions tailored to cGMP facilities and large-scale pharmaceutical collaborations.

CBD Pain AI ORAVEXX CBD composition for pain management and opioid alternatives creates potential demand for sensory analytics, formulation science partnerships, supply chain security, and digital health integrations around patient outcomes.

Clinical Collaboration Active engagement with investigator-initiated FDA trials and partnerships with research institutions presents a channel for sponsored research platforms, data management, regulatory submission support, and CRO/clinical operations services.